Cardiovascular Disease in Patients with CKD - USRDS 2012 Report
Explore the prevalence, interventions, and outcomes of cardiovascular disease in patients with Chronic Kidney Disease (CKD) based on the United States Renal Data System's 2012 Annual Data Report. The data includes information on Medicare enrollees aged 66 and older, highlighting rates of fatal and non-fatal events, diagnostic testing for patients with Congestive Heart Failure (CHF), and probabilities of death following various cardiovascular events.
Download Presentation
Please find below an Image/Link to download the presentation.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author. If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.
You are allowed to download the files provided on this website for personal or commercial use, subject to the condition that they are used lawfully. All files are the property of their respective owners.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author.
E N D
Presentation Transcript
CKD: Chapter 4 Cardiovascular disease in patients with CKD United States Renal Data System 2012 Annual Data Report
Cardiovascular disease in patients with or without CKD Figure 4.1 (volume 1) December 31, 2005 & 2010 point prevalent Medicare enrollees, age 66 & older, with fee-for- service coverage for the entire calendar year. USRDS 2012 ADR
Cardiovascular disease & intervention (percent), by CKD stage, age, & race, 2010 Table 4.a (volume 1) December 31, 2010 point prevalent Medicare enrollees, age 66 & older. Caption USRDS 2012 ADR
Cardiovascular disease & intervention (percent), by CKD stage, age, & race, 2010 Table 4.a (continued, volume 1) December 31, 2010 point prevalent Medicare enrollees, age 66 & older. USRDS 2012 ADR
Patients with CHF who receive diagnostic testing, by CKD status Figure 4.2 (volume 1) Jan. 1 pt. prev. Medicare pts. age 66 & older; first CHF diag. in 2000 or 2010 USRDS 2012 ADR
Rates of fatal & non-fatal AMI, by CKD status Figure 4.3 (volume 1) Jan. 1 pt. prev. Medicare pts. age 66 & older; first AMI event in 2007 or 2010 USRDS 2012 ADR
Probability of death following an AMI, by CKD status, 2010 Figure 4.4 (volume 1) Jan. 1 pt. prev. Medicare pts. age 66 & older; first CVD diag. in 2007 2008. USRDS 2012 ADR
Probability of death following a CVA/TIA, by CKD status Figure 4.5 (volume 1) Jan. 1 pt. prev. Medicare pts. age 66 & older; first CVD diag. in 2007 2008. USRDS 2012 ADR
Probability of death following a diagnosis of CHF, by CKD status, 2010 Figure 4.6 (volume 1) Jan. 1 pt. prev. Medicare pts. age 66 & older; first CVD diag. in 2007 2008. USRDS 2012 ADR
Probability of death following a CV procedure (PCI/CABG), by CKD status, 2010 Figure 4.7 (volume 1) Jan. 1 pt. prev. Medicare pts. age 66 & older; first CVD diag. in 2007 2008. USRDS 2012 ADR
Cardiovascular disease & pharmacological interventions (row percent), by diagnosis & CKD stage Table 4.b (volume 1) January 1 point prevalent Medicare patients with Medicare Parts A, B, & D enrollment. USRDS 2012 ADR
Cardiovascular disease & pharmacological interventions (row percent), by diagnosis & CKD stage Table 4.b (continued, volume 1) January 1 point prevalent Medicare patients with Medicare Parts A, b, & d enrollment. USRDS 2012 ADR
Utilization of cardiac drugs, by drug class & CKD status, 2010 Figure 4.8 (volume 1) January 1 point prevalent patients with Medicare Parts A, B, & D enrollment, with a first diagnosis of CHF or MI in the year; patients with baseline disease are excluded. USRDS 2012 ADR
Event-free & overall survival following a diagnosis of CHF, by CKD status & drug use, 2010 Figure 4.9 (volume 1) January 1 point prevalent patients with Medicare Parts A, B, & D enrollment, with a first diagnosis of CHF in the year; patients with baseline disease are excluded. USRDS 2012 ADR
Event-free & overall survival following an AMI, by CKD status & drug use, 2010 Figure 4.10 (volume 1) January 1 point prevalent patients with Medicare Parts A, B, & D enrollment, with a first diagnosis of MI in the year; patients with baseline disease are excluded. USRDS 2012 ADR
